Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Janssen Pharmaceutical Ltd.

Division of Johnson & Johnson

Latest From Janssen Pharmaceutical Ltd.

2015 REVIEW: China - Quality The Watchword In String Of CFDA Reforms

2015 has seen a plethora of regulatory changes and policy rewinding for China, by many measures now the world's largest pharmaceutical market. If you missed some of the major news during the year, here is your opportunity to check out the top China pharma regulatory happenings in 2015 with the help of one easy to digest infographic.

BioPharmaceutical China

‘Strategic Decision’ Prompts Janssen Exit From Chi-Med Deal

One of the largest collaborative deals in China’s pharmaceutical industry has fallen apart, as Janssen has opted to terminate an R&D alliance agreement in the inflammation/immunology area with Hutchison China MediTech, although the two firms intend to continue to work together in other areas.

BioPharmaceutical China

To Meet Demand, Forma Aims To Boost Discovery Supply

Forma Therapeutics has already convinced several big industry partners its discovery engine will yield oncology candidates in emerging areas of research. Now it wants to find academic groups to help feed its engine, all while the resurgent biotech IPO market might make its unusual structure superfluous.

BioPharmaceutical United States

Forma To Rev Its Discovery Engine For Deubiquitination

In a new collaboration with Cancer Research Technology, drug-discovery firm Forma Therapeutics adds another area of cancer biology – and another unusual deal structure – to its panoply of partnerships.

BioPharmaceutical United Kingdom
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register